SENS · Senseonics Holdings, Inc.
Market Cap
$495.96M
Shares
52.87M
SENS metrics
67 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$9.94
Market cap
$495.96M
Price action
19 metricsPrice change (1W)
-1.5%
Price change (30D)
+79.5%
Price change (3M)
+36.5%
Price change (6M)
+37.4%
Price change (YTD)
+69.9%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
82.7%
Beta
2.3
RSI (14D)
71.7
Price vs SMA 50
+44.6%
Price vs SMA 200
+42.0%
Avg volume (3M)
726,337
Relative volume
1.2
Average dollar volume
$4.87M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
52.87M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
8.4×
reciprocal yield 11.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
10.2×
reciprocal yield 9.8%
P / book
5.5
reciprocal yield 18.2%
FCF yield
-19.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-22.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
10.6×
reciprocal yield 9.5%
EV / revenue historical average (5Y)
28.1×
reciprocal yield 3.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
54.9%
Operating margin
-223.2%
Trailing 12 months
Net margin
-225.3%
Gross profit (TTM)
$26.64M
Operating profit (TTM)
−$108.36M
Net income (TTM)
−$109.38M
Trailing 12 months
Diluted EPS (TTM)
$-2.24
FCF margin
-199.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+117.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$48.55M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+42.2%
Year over year · more shares
Revenue CAGR (3Y)
+29.1%
Revenue CAGR (5Y)
+48.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-121.1%
Return on assets
-61.9%
Debt / equity
0.6
Current ratio
6.7
EBITDA (TTM)
−$106.51M
Free cash flow (TTM)
−$96.83M
Quick ratio
6.4
Interest coverage
-21.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$86.85M
Latest balance sheet
Cash & equivalents
$44.75M
Total assets
$176.84M
Total debt
$55.81M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$95.94M
Capital expenditures (TTM)
$886,000
R&D (TTM)
$36.83M
SG&A (TTM)
$98.17M
Stock compensation (TTM)
$11.27M
R&D / revenue
75.9%
Stock compensation / revenue
23.2%
Ownership (13F)
3 metrics13F filers
111
13F filer change QoQ
+22
Institutional ownership
40.2%
Short interest
3 metricsShort interest
11.1%
Latest settlement · 6.4 days to cover
Days to cover
6.4d
Short-squeeze score
70 / 100
Insider activity
2 metricsNet insider buying (90D)
$125,298
Insider-sentiment score
80 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1616543
CUSIP
81727U303
13F (30d)
94 filings
93 filers
Visit website
Investor relations